BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AGIOS PHARMACEUTICALS INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

AGIOS PHARMACEUTICALS INC.

via TIBER CREEK GROUP

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 16, 2021Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: AGIOS PHARMACEUTICALS INC.
Description: Pharmaceutical company.
Location: Massachusetts · United States of America

Registrant

Firm: TIBER CREEK GROUP
Description: Government Relations.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to pharmaceutical pricing; Issues related to treatments for rare diseases.
LobbyistsJONATHON JONES · ANDREW MCKECHNIE
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.